Pre-Cure

About

Funding history · 1 round · — total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Pre-Cure's core technology for cancer treatment selection?

Pre-Cure utilizes a multifunctional tumor-on-a-chip technology, which they describe as transforming an “organ-on-a-chip” into a “patient-on-a-chip” to reflect the entire clinical journey for individual therapy predictions.

When was Pre-Cure founded?

Pre-Cure was founded in May 2023.

What is the current employee count for Pre-Cure?

Pre-Cure currently has 7 employees.

What was Pre-Cure's most recent funding round?

Pre-Cure completed a Pre-Seed funding round in April 2023.

Which geographic markets does Pre-Cure target?

Pre-Cure targets the North America and Europe geographic markets.

What is Pre-Cure's primary sector classification?

Pre-Cure's primary sector is Health Tech & Life Sciences.

Who is a co-founder of Pre-Cure?

Dan Simhon is a co-founder of Pre-Cure.

Has Pre-Cure been involved in any collaborations related to space research?

In January 2022, Pre-Cure's team collaborated with the Israel Space Agency and Hebrew University to send cancer cells and anti-cancer nanomedicine to space.

Sectors & technology

Highlights

Tags